Dermatology · Mobile, AL
NPI
1649266792
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
580 Providence Park Dr E, 2nd Floor
Mobile, AL, 36695
Phone (251) 631-3570
Groups this clinician bills Medicare through
Medicare paid, 2024
$547K
14,083 services
Medicare patients, 2024
1,134
Average age 75
Drug cost, 2024
$1.4M
3,181 prescriptions
Company payments, 2025
$29K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas W Bender III was code 17003 (destruction skin lesion), 5,860 times for 727 patients. In total Thomas W Bender III billed 14,083 services in 51 codes, and Medicare paid $547K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 5,860 | 727 | $4.45 | $26K |
| 17000 Destruction Skin Lesion | Office | 1,383 | 811 | $35.21 | $49K |
| 99213 Office E&M - Established | Office | 1,347 | 754 | $57.11 | $77K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 563 | 58 | $128.37 | $72K |
| 77280 Radiation Treatment Planning | Office | 524 | 53 | $192.54 | $101K |
| 77401 Conventional Radiation Treatment | Office | 496 | 51 | $29.38 | $15K |
| 17110 Destruction Skin Lesion | Office | 389 | 321 | $72.44 | $28K |
| 99214 Office E&M - Established | Office | 306 | 234 | $79.60 | $24K |
| 11102 Skin Biopsy | Office | 281 | 244 | $60.44 | $17K |
| 99203 Office E&M - New | Office | 93 | 93 | $64.95 | $6,041 |
| 17004 Destruction Skin Lesion | Office | 92 | 63 | $111.18 | $10K |
| 11602 Skin Lesion Excision | Office | 83 | 78 | $90.04 | $7,473 |
| 99212 Office E&M - Established | Office | 81 | 71 | $40.23 | $3,259 |
| 96567 Skin | Office | 67 | 51 | $87.40 | $5,856 |
| 13121 Wound Repair - All Levels | Office | 61 | 57 | $291.71 | $18K |
By year: 2022 $618K for 13,241 services; 2023 $584K for 12,761 services; 2024 $547K for 14,083 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas W Bender III prescribed most often to Medicare patients was Ketoconazole, with 750 prescriptions and refills. In total Thomas W Bender III wrote 3,181 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 750 | 797 | 305 | $15K |
| Triamcinolone Acetonide Generic | 455 | 511 | 297 | $7,556 |
| Clobetasol Propionate Generic | 287 | 308 | 174 | $13K |
| Hydrocortisone Generic | 213 | 253 | 131 | $1,934 |
| Levocetirizine Dihydrochloride Generic | 146 | 204 | 66 | $1,340 |
| Minocycline Hcl Generic | 139 | 149 | 75 | $4,391 |
| Metronidazole Generic | 118 | 129 | 64 | $5,610 |
| Mupirocin Generic | 103 | 108 | 71 | $976 |
| Dupixent Pen Dupilumab | 95 | 95 | 14 | $374K |
| Azelaic Acid Generic | 89 | 91 | 51 | $9,507 |
| Tacrolimus Generic | 69 | 69 | 43 | $11K |
| Terbinafine Hcl Generic | 66 | 110 | 35 | $405 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 64 | 68 | 25 | $4,183 |
| Ciclopirox Generic | 63 | 77 | 29 | $1,727 |
| Clindamycin Phosphate Generic | 44 | 50 | 29 | $1,461 |
Brand drugs: 209 claims; generic drugs: 2,972 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas W Bender III $29K ($29K in general payments such as food, travel and fees) from 24 companies. The largest payer was Organon LLC with $15K.
| Company | Payments | Amount |
|---|---|---|
| Organon LLC OGN | 33 | $15K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 17 | $9,959 |
| Abbvie Inc. ABBV | 42 | $704 |
| Novartis Pharmaceuticals Corporation NVS | 25 | $372 |
| Lilly USA, LLC LLY | 6 | $363 |
| Janssen Biotech, Inc. JNJ | 10 | $315 |
| Incyte Corporation INCY | 7 | $308 |
| Pfizer Inc. PFE | 11 | $274 |
| Galderma Laboratories, L.P. GALD.SW | 10 | $204 |
| Genzyme Corporation SNY | 5 | $190 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.